These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 10344755)
21. Allelic loss mapping and physical delineation of a region harboring a putative thymic lymphoma suppressor gene on mouse chromosome 12. Shinbo T; Matsuki A; Matsumoto Y; Kosugi S; Takahashi Y; Niwa O; Kominami R Oncogene; 1999 Jul; 18(28):4131-6. PubMed ID: 10435594 [TBL] [Abstract][Full Text] [Related]
22. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC). Singh RB; Amare Kadam PS Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529 [TBL] [Abstract][Full Text] [Related]
23. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in F1 hybrid min mice: evidence for sequential loss of APC(+) and Dpc4 in tumor development. Haines J; Dunford R; Moody J; Ellender M; Cox R; Silver A Genes Chromosomes Cancer; 2000 Aug; 28(4):387-94. PubMed ID: 10862047 [TBL] [Abstract][Full Text] [Related]
25. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
26. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522 [TBL] [Abstract][Full Text] [Related]
27. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16. Dietrich WF; Radany EH; Smith JS; Bishop JM; Hanahan D; Lander ES Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9451-5. PubMed ID: 7937788 [TBL] [Abstract][Full Text] [Related]
28. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Pollock PM; Welch J; Hayward NK Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846 [TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts. Obata M; Lee GH; Kanda H; Kitagawa T; Ogawa K Mol Carcinog; 1997 May; 19(1):17-24. PubMed ID: 9180924 [TBL] [Abstract][Full Text] [Related]
30. Loss of heterozygosity on chromosomes 1, 11, 12, and 14 in hybrid mouse lung adenocarcinomas. Herzog CR; Chen B; Wang Y; Schut HA; You M Mol Carcinog; 1996 Jun; 16(2):83-90. PubMed ID: 8645430 [TBL] [Abstract][Full Text] [Related]
31. Somatic mutations that contribute to breast cancer. Callahan R Biochem Soc Symp; 1998; 63():211-21. PubMed ID: 9513725 [TBL] [Abstract][Full Text] [Related]
32. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis]. Xu X; An Q; Zhang J; Tang P; Cheng S Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947 [TBL] [Abstract][Full Text] [Related]
34. Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Montagna C; Andrechek ER; Padilla-Nash H; Muller WJ; Ried T Oncogene; 2002 Jan; 21(6):890-8. PubMed ID: 11840334 [TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Parangi S; Dietrich W; Christofori G; Lander ES; Hanahan D Cancer Res; 1995 Dec; 55(24):6071-6. PubMed ID: 8521395 [TBL] [Abstract][Full Text] [Related]
36. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Herzog CR; Wiseman RW; You M Cancer Res; 1994 Aug; 54(15):4007-10. PubMed ID: 8033131 [TBL] [Abstract][Full Text] [Related]
37. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma. Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874 [TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity in malignant rat schwannomas chemically induced in hybrids of inbred rat strains with differential tumor susceptibility. Koelsch BU; Kindler-Röhrborn A; Held S; Zabel S; Rajewsky MF Carcinogenesis; 2002 Jun; 23(6):1033-7. PubMed ID: 12082026 [TBL] [Abstract][Full Text] [Related]
39. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Jacquemart IC; Springs AE; Chen WY Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488 [TBL] [Abstract][Full Text] [Related]
40. Analysis of highly frequent allelic loss region on distal chromosome 12 in murine radiation-induced lymphomas. Park YG; Song CW; Mori N; Sugimoto K; Hong DP; Okumoto M Cancer Lett; 2000 Jan; 148(1):95-103. PubMed ID: 10680598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]